Ally Bridge Group Investor
Ally Bridge Group is a global healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing.
Technology:
Cell_Therapies, Geroscience
Industry:
Investor
Headquarters:
Hong Kong, Hong Kong Island, Hong Kong
Zip:
NA
Founded Date:
2013-07-01
Employees Number:
1-10
Investor Type:
Private Equity Firm, Venture Capital
Investment Stage:
Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Secondary Market
Number Of Exits:
27
Acquisitions Number:
27
Investors Number:
71
Estimated Revenue:
$1M to $10M
Register and Claim Ownership